Gliclazide Supplier-Buyer Network — Trade Flow Analysis

Name: Gliclazide Supplier-Buyer Trade Network Dataset — 238+ Indian Exporters, 20+ Importers, 109+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Gliclazide supplier network, Gliclazide buyers, pharmaceutical export India, Gliclazide trade data

TransData Nexus

Gliclazide

India Pharmaceutical Trade Intelligence

$300.8M238 Suppliers109 CountriesHS 30049099

ExportsIndia → HUNGARY29.3%India → NETHERLANDS29.2%

ImportsUNITED KINGDOM → India$1.0M BULGARIA → India$261.6K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN HUNGARY

Who Supplies Gliclazide? Top Manufacturers & Buyers 2026 — MYLAN LABORATORIES LIMITED Leads | TransData Nexus | TransData Nexus

1MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the first-largest Gliclazide exporter from India, with a market share of 59.2% and a total export value of $178.2M across 133 shipments. Their average shipment value of $1.3M is above the market average of $78.5K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• MYLAN HUNGARY KFT, — $86.9M across 65 shipments (48.8% of this supplier's total exports)

• MYLAN B,V C/0 TJOAPA — $86.1M across 64 shipments (48.3% of this supplier's total exports)

• MYLAN PHARMACEUTICALS ULC — $4.1M across 3 shipments (2.3% of this supplier's total exports)

• MYLAN HUNGARY KFT, — $629.1K across 0 shipments (0.4% of this supplier's total exports)

• MYLAN B V — $443.4K across 0 shipments (0.2% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $1.3M is 1606% above the market average of $78.5K, consistent with large-order contracts or value-added formulations.

2PANACEA BIOTEC PHARMA LIMITED

PANACEA BIOTEC PHARMA LIMITED is the second-largest Gliclazide exporter from India, with a market share of 12.5% and a total export value of $37.5M across 50 shipments. Their average shipment value of $750.9K is above the market average of $78.5K, suggesting premium or bulk contract pricing.

PANACEA BIOTEC PHARMA LIMITED serves 5 named buyers in our database. DANANG PHARMACEUTICAL MEDICAL EQUIP is the dominant customer, accounting for 83.3% of this supplier's tracked business. Top customers include:

• DANANG PHARMACEUTICAL MEDICAL EQUIP — $31.3M across 42 shipments (83.3% of this supplier's total exports)

• M/S. BIOGENETECH CO. — $5.7M across 8 shipments (15.2% of this supplier's total exports)

• BIOGENETECH CO. LTD, — $202.0K across 0 shipments (0.5% of this supplier's total exports)

• M S BIOGENETECH CO L — $182.1K across 0 shipments (0.5% of this supplier's total exports)

• SOHACO TRADING AND PHARMACEUTICAL — $172.0K across 0 shipments (0.5% of this supplier's total exports)

Key Insight: PANACEA BIOTEC PHARMA LIMITED's per-shipment value of $750.9K is 856% above the market average of $78.5K, consistent with large-order contracts or value-added formulations.

3SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the third-largest Gliclazide exporter from India, with a market share of 2.1% and a total export value of $6.3M across 470 shipments. Their average shipment value of $13.5K is below the market average of $78.5K, reflecting a high-volume, competitive pricing strategy.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• RANBAXY FARMACEUTICA LTDA : — $2.3M across 169 shipments (35.9% of this supplier's total exports)

• SUN PHARMA CANADA INC. — $1.9M across 139 shipments (29.6% of this supplier's total exports)

• M S RANBAXY FARMACEU — $766.5K across 57 shipments (12.1% of this supplier's total exports)

• MS RANBAXY FARMACEUT — $750.3K across 56 shipments (11.9% of this supplier's total exports)

• RANBAXY FARMACEUTICA LTDA : — $667.9K across 50 shipments (10.6% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (470 shipments) at a per-shipment value of $13.5K, indicating a broad distribution network with many smaller, regular orders.

4MICRO LABS LIMITED

MICRO LABS LIMITED is the fourth-largest Gliclazide exporter from India, with a market share of 1.7% and a total export value of $5.0M across 205 shipments. Their average shipment value of $24.3K is below the market average of $78.5K, reflecting a high-volume, competitive pricing strategy.

MICRO LABS LIMITED serves 5 named buyers in our database. CENTRAL PHARMACEUTICAL JOINT STOCK is the dominant customer, accounting for 52.4% of this supplier's tracked business. Top customers include:

• CENTRAL PHARMACEUTICAL JOINT STOCK — $2.6M across 107 shipments (52.4% of this supplier's total exports)

• BROWN AND BURK PHILI — $855.9K across 35 shipments (17.2% of this supplier's total exports)

• CENTRAL PHARMACEUTICAL JOINT STOCK — $508.4K across 21 shipments (10.2% of this supplier's total exports)

• SOHACO TRADING AND PHARMACEUTICAL — $505.7K across 21 shipments (10.2% of this supplier's total exports)

• CENTRAL PHARMACEUTICAL JOINT STOCK — $499.6K across 21 shipments (10.0% of this supplier's total exports)

Key Insight: MICRO LABS LIMITED operates with high shipment frequency (205 shipments) at a per-shipment value of $24.3K, indicating a broad distribution network with many smaller, regular orders.

5IPCA LABORATORIES LIMITED

IPCA LABORATORIES LIMITED is the fifth-largest Gliclazide exporter from India, with a market share of 1.6% and a total export value of $4.9M across 243 shipments. Their average shipment value of $20.3K is below the market average of $78.5K, reflecting a high-volume, competitive pricing strategy.

IPCA LABORATORIES LIMITED serves 5 named buyers in our database. DELTA IMPORT EXPORT MEDICAL CO., LT is the dominant customer, accounting for 67.4% of this supplier's tracked business. Top customers include:

• DELTA IMPORT EXPORT MEDICAL CO., LT — $3.3M across 164 shipments (67.4% of this supplier's total exports)

• THE MAURITIUS PHARMA — $653.0K across 32 shipments (13.2% of this supplier's total exports)

• NA — $619.1K across 30 shipments (12.6% of this supplier's total exports)

• BLUE GLOBAL (FZE) — $179.0K across 9 shipments (3.6% of this supplier's total exports)

• DELTA IMPORT EXPORT MEDICAL CO., LT — $157.6K across 8 shipments (3.2% of this supplier's total exports)

Key Insight: IPCA LABORATORIES LIMITED operates with high shipment frequency (243 shipments) at a per-shipment value of $20.3K, indicating a broad distribution network with many smaller, regular orders.

6TORRENT PHARMACEUTICALS LTD

TORRENT PHARMACEUTICALS LTD is the fifth-largest Gliclazide exporter from India, with a market share of 1.0% and a total export value of $3.0M across 217 shipments. Their average shipment value of $14.0K is below the market average of $78.5K, reflecting a high-volume, competitive pricing strategy.

TORRENT PHARMACEUTICALS LTD serves 4 named buyers in our database. TORRENT DO BRASIL LTDA is the dominant customer, accounting for 91.6% of this supplier's tracked business. Top customers include:

• TORRENT DO BRASIL LTDA — $2.8M across 199 shipments (91.6% of this supplier's total exports)

• HATTON NATIONAL BANK — $192.2K across 14 shipments (6.3% of this supplier's total exports)

• HATTON NATIONAL BANK — $52.2K across 4 shipments (1.7% of this supplier's total exports)

• TO THE ORDER OF — $10.5K across 1 shipments (0.3% of this supplier's total exports)

Key Insight: TORRENT PHARMACEUTICALS LTD operates with high shipment frequency (217 shipments) at a per-shipment value of $14.0K, indicating a broad distribution network with many smaller, regular orders.

1Hungary

Hungary ranks as the first-largest destination for Gliclazide imports from India, with a total trade value of $88.2M across 21 shipments — representing a 29.3% share of all Gliclazide exports. The average shipment value of $4.2M is above the global average of $78.5K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Gliclazide importers in Hungary: MYLAN HUNGARY KFT, is the largest buyer, accounting for 98.8% ($87.1M) of this market's total imports.

• MYLAN HUNGARY KFT, — $87.1M (98.8% of Hungary's total)

Key Insight: Hungary's per-shipment average of $4.2M (5246% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Hungary is a key market for Gliclazide imports from India.

Primary Market

Secondary Market

2Netherlands

Netherlands ranks as the second-largest destination for Gliclazide imports from India, with a total trade value of $87.7M across 0 shipments — representing a 29.2% share of all Gliclazide exports. The average shipment value of $87.7M is above the global average of $78.5K, indicating high-value procurement contracts or branded formulations.

Key Insight: Netherlands's per-shipment average of $87.7M (111615% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Netherlands is a key market for Gliclazide imports from India.

Primary Market

Secondary Market

3Vietnam

Vietnam ranks as the third-largest destination for Gliclazide imports from India, with a total trade value of $41.8M across 77 shipments — representing a 13.9% share of all Gliclazide exports. The average shipment value of $542.8K is above the global average of $78.5K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Gliclazide importers in Vietnam: DANANG PHARMACEUTICAL MEDICAL EQUIP is the largest buyer, accounting for 74.8% ($31.3M) of this market's total imports.

• DANANG PHARMACEUTICAL MEDICAL EQUIP — $31.3M (74.8% of Vietnam's total)

• DELTA IMPORT EXPORT MEDICAL CO., LT — $3.4M (8.2% of Vietnam's total)

• CENTRAL PHARMACEUTICAL JOINT STOCK — $3.2M (7.8% of Vietnam's total)

Key Insight: Vietnam's per-shipment average of $542.8K (591% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Vietnam is a key market for Gliclazide imports from India.

Primary Market

Secondary Market

4Brazil

Brazil ranks as the fourth-largest destination for Gliclazide imports from India, with a total trade value of $20.7M across 408 shipments — representing a 6.9% share of all Gliclazide exports. The average shipment value of $50.7K is below the global average of $78.5K, consistent with generic/API volume purchasing. This market is served by 4 tracked buyers.

Named Gliclazide importers in Brazil: TORRENT DO BRASIL LTDA is the largest buyer, accounting for 31.6% ($6.5M) of this market's total imports.

• TORRENT DO BRASIL LTDA — $6.5M (31.6% of Brazil's total)

• M/S. RANBAXY FARMACEUTICA LTDA : — $2.4M (11.7% of Brazil's total)

• RANBAXY FARMACEUTICA LTDA : — $2.3M (11.0% of Brazil's total)

Key Insight: Brazil receives frequent, smaller shipments of Gliclazide — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Brazil is a key market for Gliclazide imports from India.

Primary Market

Secondary Market

5Philippines

Philippines ranks as the fifth-largest destination for Gliclazide imports from India, with a total trade value of $8.3M across 0 shipments — representing a 2.8% share of all Gliclazide exports. The average shipment value of $8.3M is above the global average of $78.5K, indicating high-value procurement contracts or branded formulations.

Key Insight: Philippines's per-shipment average of $8.3M (10463% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Philippines is a key market for Gliclazide imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Gliclazide.
2.Flow Mapping: 238 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 3,830 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 109 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

3,830 Verified Shipments

238 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Gliclazide

Gliclazide

Who Supplies Gliclazide? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Gliclazide? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Gliclazide Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1MYLAN LABORATORIES LIMITED

2PANACEA BIOTEC PHARMA LIMITED

3SUN PHARMACEUTICAL INDUSTRIES LIMITED

4MICRO LABS LIMITED

5IPCA LABORATORIES LIMITED

6TORRENT PHARMACEUTICALS LTD

From Indian Factories to Global Pharmacies — How Gliclazide Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Gliclazide Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Hungary

2Netherlands

3Vietnam

4Brazil

5Philippines

People Also Ask — Gliclazide Supplier & Trade Network

Gliclazide Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology